Article

AMO introduces next-generation, one-piece IOL in the United States

Advanced Medical Optics (AMO) announced the U.S. introduction of its next-generation, one-piece IOL (Tecnis) with design enhancements that target zero spherical aberration and improve night-driving simulator performance, according to the company.

Advanced Medical Optics (AMO) announced the U.S. introduction of its next-generation, one-piece IOL (Tecnis) with design enhancements that target zero spherical aberration and improve night-driving simulator performance, according to the company.

A 360-degree edge design (ProTec, AMO) provides an uninterrupted barrier edge to minimize cell migration to the posterior capsule. Unlike first-generation, one-piece lenses, the new lens has no interruption at the haptic-optic junction, according to the company. The lens also features a frosted edge to minimize edge glare. In addition, three-point fixation (Tri-Fix, AMO) provides stability. Refraction stabilizes quickly after the implantation procedure.

Made from a hydrophobic acrylic material that blocks ultraviolet light, the lens transmits the blue light needed for improved scotopic vision and healthy circadian rhythms. The IOL's one-piece design and reduced center thickness enable simple implantation with bag-friendly coplanar delivery and gentle unfolding haptics, the company said.

The lens has been designated as a New Technology Intraocular Lens by the Centers for Medicare and Medicaid Services.

For more information, visit AMO at booths 1328 and 1628.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.